SERA peer analysis
Sera Prognostics (SERA) against its competitors: price, today's move, 1-year return and market value side by side.
- SERA's peers: APYX (Apyx Medical), ATOS (Atossa Therapeutics), CGTX (Cognition Therapeutics), HURA (TuHURA Biosciences), LUCD (Lucid Diagnostics), ONCY (Oncolytics Biotech), RPID (Rapid Micro Biosystems), SRZN (Surrozen).
SERA and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| APYX Apyx Medical | $2.39 | -4.02% | -39.49% | $100.68M |
| ATOS Atossa Therapeutics | $1.65 | -5.71% | -85.59% | $16.47M |
| CGTX Cognition Therapeutics | $0.60 | 0.10% | -56.79% | $57.12M |
| HURA TuHURA Biosciences | $1.36 | -0.73% | -22.29% | $89.43M |
| LUCD Lucid Diagnostics | $0.38 | -2.93% | -63.24% | $73.02M |
| ONCY Oncolytics Biotech | $0.39 | -11.29% | -62.44% | $53.18M |
| RPID Rapid Micro Biosystems | $0.74 | -0.31% | -83.14% | $37.38M |
| SRZN Surrozen | $28.41 | -7.37% | 110.44% | $212.43M |
| TVGN Tevogen Bio | $6.30 | 2.61% | -69.20% | $26.23M |
| SERA Sera Prognostics | $1.89 | -1.05% | -40.94% | $73.34M |